BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 16913701)

  • 1. N1-Benzoyl-N2-[1-(1-naphthyl)ethyl]-trans-1,2-diaminocyclohexanes: Development of 4-chlorophenylcarboxamide (calhex 231) as a new calcium sensing receptor ligand demonstrating potent calcilytic activity.
    Kessler A; Faure H; Petrel C; Rognan D; Césario M; Ruat M; Dauban P; Dodd RH
    J Med Chem; 2006 Aug; 49(17):5119-28. PubMed ID: 16913701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N(1)-Arylsulfonyl-N(2)-(1-(1-naphthyl)ethyl)-1,2-diaminocyclohexanes: a new class of calcilytic agents acting at the calcium-sensing receptor.
    Kessler A; Faure H; Roussanne MC; Ferry S; Ruat M; Dauban P; Dodd RH
    Chembiochem; 2004 Aug; 5(8):1131-6. PubMed ID: 15300839
    [No Abstract]   [Full Text] [Related]  

  • 3. N2-benzyl-N1-(1-(1-naphthyl)ethyl)-3-phenylpropane-1,2-diamines and conformationally restrained indole analogues: development of calindol as a new calcimimetic acting at the calcium sensing receptor.
    Kessler A; Faure H; Petrel C; Ruat M; Dauban P; Dodd RH
    Bioorg Med Chem Lett; 2004 Jun; 14(12):3345-9. PubMed ID: 15149704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular determinants of non-competitive antagonist binding to the mouse GPRC6A receptor.
    Faure H; Gorojankina T; Rice N; Dauban P; Dodd RH; Bräuner-Osborne H; Rognan D; Ruat M
    Cell Calcium; 2009; 46(5-6):323-32. PubMed ID: 19836834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modeling and mutagenesis of the binding site of Calhex 231, a novel negative allosteric modulator of the extracellular Ca(2+)-sensing receptor.
    Petrel C; Kessler A; Maslah F; Dauban P; Dodd RH; Rognan D; Ruat M
    J Biol Chem; 2003 Dec; 278(49):49487-94. PubMed ID: 14506236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro effects of strontium ranelate on the extracellular calcium-sensing receptor.
    Coulombe J; Faure H; Robin B; Ruat M
    Biochem Biophys Res Commun; 2004 Oct; 323(4):1184-90. PubMed ID: 15451421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of novel and potent orally active calcium-sensing receptor antagonists that stimulate pulselike parathyroid hormone secretion: synthesis and structure-activity relationships of tetrahydropyrazolopyrimidine derivatives.
    Yoshida M; Mori A; Kotani E; Oka M; Makino H; Fujita H; Ban J; Ikeda Y; Kawamoto T; Goto M; Kimura H; Baba A; Yasuma T
    J Med Chem; 2011 Mar; 54(5):1430-40. PubMed ID: 21306167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N1-Arylsulfonyl-N2-(1-aryl)ethyl-3-phenylpropane-1,2-diamines as novel calcimimetics acting on the calcium sensing receptor.
    Dauban P; Ferry S; Faure H; Ruat M; Dodd RH
    Bioorg Med Chem Lett; 2000 Sep; 10(17):2001-4. PubMed ID: 10987436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel diastereomeric opioid tetrapeptides exhibit differing pharmacological activity profiles.
    Ioja E; Tourwé D; Kertész I; Tóth G; Borsodi A; Benyhe S
    Brain Res Bull; 2007 Sep; 74(1-3):119-29. PubMed ID: 17683797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Positive and negative allosteric modulators of the Ca2+-sensing receptor interact within overlapping but not identical binding sites in the transmembrane domain.
    Petrel C; Kessler A; Dauban P; Dodd RH; Rognan D; Ruat M
    J Biol Chem; 2004 Apr; 279(18):18990-7. PubMed ID: 14976203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcilytics inhibit the proliferation and migration of human prostate cancer PC-3 cells.
    Yamamura A; Nayeem MJ; Sato M
    J Pharmacol Sci; 2019 Mar; 139(3):254-257. PubMed ID: 30808588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and structure-activity relationships of N-{1-[(6-fluoro-2-naphthyl)methyl]piperidin-4-yl}benzamide derivatives as novel CCR3 antagonists.
    Sato I; Morihira K; Inami H; Kubota H; Morokata T; Suzuki K; Hamada N; Iura Y; Nitta A; Imaoka T; Takahashi T; Takeuchi M; Ohta M; Tsukamoto S
    Bioorg Med Chem; 2008 Jan; 16(1):144-56. PubMed ID: 17951061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of N-(3-(morpholinomethyl)-phenyl)-amides as potent and selective CB2 agonists.
    Worm K; Weaver DG; Green RC; Saeui CT; Dulay DM; Barker WM; Cassel JA; Stabley GJ; DeHaven RN; LaBuda CJ; Koblish M; Brogdon BL; Smith SA; Dolle RE
    Bioorg Med Chem Lett; 2009 Sep; 19(17):5004-8. PubMed ID: 19646869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel and potent small-molecule urotensin II receptor agonists.
    Lehmann F; Currier EA; Clemons B; Hansen LK; Olsson R; Hacksell U; Luthman K
    Bioorg Med Chem; 2009 Jul; 17(13):4657-65. PubMed ID: 19481466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The calcilytics Calhex-231 and NPS 2143 and the calcimimetic Calindol reduce vascular reactivity via inhibition of voltage-gated Ca
    Greenberg HZE; Jahan KS; Shi J; Vanessa Ho WS; Albert AP
    Eur J Pharmacol; 2016 Nov; 791():659-668. PubMed ID: 27725162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stereochemical diversity-oriented conformational restriction strategy. Development of potent histamine H3 and/or H4 receptor antagonists with an imidazolylcyclopropane structure.
    Watanabe M; Kazuta Y; Hayashi H; Yamada S; Matsuda A; Shuto S
    J Med Chem; 2006 Sep; 49(18):5587-96. PubMed ID: 16942032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and preliminary biological evaluation of (2S,1'R,2'S)- and (2S,1'S,2'R)-2-(2'-phosphonocyclopropyl)glycines, two novel conformationally constrained l-AP4 analogues.
    Amori L; Serpi M; Marinozzi M; Costantino G; Diaz MG; Hermit MB; Thomsen C; Pellicciari R
    Bioorg Med Chem Lett; 2006 Jan; 16(1):196-9. PubMed ID: 16213710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a calcium-sensing receptor molecular imaging agent.
    Yusof AM; Kothandaraman S; Zhang X; Saji M; Ringel MD; Tweedle MF; Phay JE
    Surgery; 2013 Dec; 154(6):1378-84; discussion 1384. PubMed ID: 24238055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elucidation of the bioactive conformation of the N-substituted trans-3,4-dimethyl-4-(3-hydroxyphenyl)piperidine class of mu-opioid receptor antagonists.
    Le Bourdonnec B; Goodman AJ; Michaut M; Ye HF; Graczyk TM; Belanger S; Herbertz T; Yap GP; DeHaven RN; Dolle RE
    J Med Chem; 2006 Dec; 49(25):7278-89. PubMed ID: 17149858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design and synthesis of novel sulfonamide-containing bradykinin hB2 receptor antagonists. 1. Synthesis and SAR of alpha,alpha-dimethylglycine sulfonamides.
    Fattori D; Rossi C; Fincham CI; Berettoni M; Calvani F; Catrambone F; Felicetti P; Gensini M; Terracciano R; Altamura M; Bressan A; Giuliani S; Maggi CA; Meini S; Valenti C; Quartara L
    J Med Chem; 2006 Jun; 49(12):3602-13. PubMed ID: 16759102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.